ethyl 4-((4-aminophenyl)ethynyl)-6-methoxyquinoline-2-carboxylate

ID: ALA4637708

PubChem CID: 156011178

Max Phase: Preclinical

Molecular Formula: C21H18N2O3

Molecular Weight: 346.39

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)c1cc(C#Cc2ccc(N)cc2)c2cc(OC)ccc2n1

Standard InChI:  InChI=1S/C21H18N2O3/c1-3-26-21(24)20-12-15(7-4-14-5-8-16(22)9-6-14)18-13-17(25-2)10-11-19(18)23-20/h5-6,8-13H,3,22H2,1-2H3

Standard InChI Key:  RAWAYYZHLDKMKN-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   39.2609  -22.8648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2598  -23.6843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.9678  -24.0933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.9660  -22.4559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.6746  -22.8612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.6754  -23.6802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3839  -24.0873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0922  -23.6765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0875  -22.8543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3784  -22.4510    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.7927  -22.4414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.5029  -22.8457    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.7877  -21.6243    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.2081  -22.4328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.9182  -22.8371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5517  -24.0924    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.8443  -23.6832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3856  -24.9045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3796  -25.7209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3736  -26.5381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.6594  -26.9376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.6531  -27.7540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3583  -28.1687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0714  -27.7610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0742  -26.9459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3533  -28.9859    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  9 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 14 15  1  0
  2 16  1  0
 16 17  1  0
  7 18  1  0
 18 19  3  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 23 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4637708

    ---

Associated Targets(Human)

SK-MEL-147 (77 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 346.39Molecular Weight (Monoisotopic): 346.1317AlogP: 3.40#Rotatable Bonds: 3
Polar Surface Area: 74.44Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.92CX LogP: 3.81CX LogD: 3.81
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.45Np Likeness Score: -0.77

References

1. Costa CA, Lopes RM, Ferraz LS, Esteves GNN, Di Iorio JF, Souza AA, de Oliveira IM, Manarin F, Judice WAS, Stefani HA, Rodrigues T..  (2020)  Cytotoxicity of 4-substituted quinoline derivatives: Anticancer and antileishmanial potential.,  28  (11): [PMID:32336669] [10.1016/j.bmc.2020.115511]

Source